Company Filing History:
Years Active: 2019
Title: Innovations of Chung Mo Ahn in Hepatitis B Immunoglobulin Preparation
Introduction
Chung Mo Ahn is a notable inventor based in Cheongju-si, South Korea. He has made significant contributions to the field of immunology, particularly in the preparation of hepatitis B immunoglobulin derived from human plasma. His innovative methods have the potential to enhance the quality and efficiency of immunoglobulin production.
Latest Patents
Chung Mo Ahn holds a patent for "Methods for preparing hepatitis B immunoglobulin derived from plasma." This invention focuses on a preparation method that involves dialysis concentration of plasma protein fraction II, which contains human hepatitis B immunoglobulin. The process includes the removal of thrombus-producing materials and impurities using anion and cation exchange resin purification techniques. This method improves the efficiency of impurity removal while maintaining a stable polymer content, resulting in high-quality hepatitis B immunoglobulin.
Career Highlights
Chung Mo Ahn is associated with Green Cross Holdings Corporation, where he applies his expertise in immunology and patent development. His work has contributed to advancements in the production of therapeutic proteins, particularly in the context of hepatitis B treatment.
Collaborations
Chung Mo Ahn has collaborated with notable colleagues, including Yong Uk Shin and Dong Il Park. Their combined efforts in research and development have furthered the understanding and application of immunoglobulin preparations.
Conclusion
Chung Mo Ahn's innovative methods in the preparation of hepatitis B immunoglobulin represent a significant advancement in the field of immunology. His contributions not only enhance the quality of therapeutic products but also demonstrate the importance of research and collaboration in medical advancements.